Clover Health Investments Corp
$ 2.15
2.87%
26 Feb - close price
- Market Cap 1,079,857,000 USD
- Current Price $ 2.15
- High / Low $ 2.17 / 2.08
- Stock P/E N/A
- Book Value 0.66
- EPS -0.11
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.06 %
- ROE -0.17 %
- 52 Week High 4.05
- 52 Week Low 1.94
About
Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$3.23
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-04 | 2025-05-05 | 2025-03-10 | 2024-11-06 | 2024-08-05 | 2024-05-07 | 2024-03-12 | 2023-11-06 | 2023-08-08 | 2023-05-09 | 2023-02-28 |
| Reported EPS | -0.05 | 0.0329 | 0.051 | -0.05 | -0.02 | 0.01 | -0.04 | -0.14 | -0.09 | -0.06 | -0.15 | -0.17 |
| Estimated EPS | -0.01 | -0.0187 | -0.07 | -0.065 | -0.04 | -0.05 | -0.07 | -0.14 | -0.11 | -0.15 | -0.18 | -0.26 |
| Surprise | -0.04 | 0.0516 | 0.121 | 0.015 | 0.02 | 0.06 | 0.03 | 0 | 0.02 | 0.09 | 0.03 | 0.09 |
| Surprise Percentage | -400% | 275.9358% | 172.8571% | 23.0769% | 50% | 120% | 42.8571% | 0% | 18.1818% | 60% | 16.6667% | 34.6154% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.11 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CLOV
2026-01-31 00:58:46
Clover Health Investments, Corp. (CLOV) announced it will release its fourth quarter and full year 2025 financial results after market close on February 26, 2026, followed by a webcast at 5:00 p.m. ET. The company, which focuses on providing healthcare to Medicare recipients through its software platform Clover Assistant, will discuss its financial performance and business updates. Investors can register for the webcast through the Investor Relations section of Clover Health's website.
2026-01-29 21:19:00
Clover Health Investments, Corp. (CLOV) announced it will release its fourth quarter and full year 2025 financial results after market close on February 26, 2026. Management will host a webcast at 5:00 p.m. ET to discuss the results and business updates. The company is focused on providing healthcare access to Medicare recipients, leveraging its Clover Assistant software platform to improve clinical decision-making and health outcomes.
2026-01-21 13:58:15
Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 4,597 shares for $11,860 on January 20, 2026, and an additional 14,732 shares for $41,396 on January 15, 2026, to cover tax obligations. Despite the company not being profitable in the last year, InvestingPro projects profitability in the current year, and analysts view the stock as slightly undervalued with price targets between $3.00 and $3.70. Clover Health also reported a significant increase in Medicare Advantage membership and aims for its first full-year GAAP Net Income profitability in 2026, though it missed Q3 2025 EPS estimates while exceeding revenue expectations.
2026-01-21 00:28:07
Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, sold 4,597 shares of Class A Common Stock for $11,860 on January 20, 2026, and an additional 14,732 shares for $41,396 on January 15, 2026, to cover tax obligations. Despite not being profitable in the past year, InvestingPro analysis anticipates Clover Health will achieve profitability this year, with a projected GAAP Net Income profitability in 2026. The company also reported a 53% year-over-year increase in Medicare Advantage membership and its stock is considered slightly undervalued by InvestingPro.
2026-01-17 15:27:35
U.S. stocks traded lower on Wednesday, with the Nasdaq falling significantly, despite energy shares gaining and U.S. retail sales increasing by 0.6% in November. Several companies saw substantial stock movements: High Roller Technologies surged 289% following a new partnership, Clover Health Investments rose 10% on membership growth, and Inspire Veterinary Partners gained 78%. Conversely, BriaCell Therapeutics and Plus Therapeutics dropped over 30% after pricing public offerings, while Hub Cyber Security fell 39% following a reverse stock split.
2026-01-14 13:46:00
Clover Health announced a significant 53% year-over-year increase in its Medicare Advantage membership for 2026, reaching approximately 153,000 members. This growth, driven by strategic market approaches and strong retention, positions the company for its first full year of GAAP Net Income profitability in 2026. Clover's PPO plan, which covers over 97% of its members, leads nationally in clinical quality, supported by its Clover Assistant technology to enhance patient outcomes.
